Jiang Feng, Yang Wan-Li, Wang Jia-Wei, Zhu Zhen, Luo Ceng, Arendt-Nielsen Lars, Song Xue-Jun
Translational Institute for Cancer Pain, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch, Shanghai, China.
School of Life Sciences, Shanghai University, Shanghai, China.
Pain Rep. 2021 May 10;6(1):e931. doi: 10.1097/PR9.0000000000000931. eCollection 2021.
The coronavirus disease 2019 (COVID-19) global pandemic poses a major threat to human health and health care systems. Urgent prevention and control measures have obstructed patients' access to pain treatment, and many patients with pain have been unable to receive adequate and timely medical services. Many patients with COVID-19 report painful symptoms including headache, muscle pain, and chest pain during the initial phase of the disease. Persistent pain sequela in patients with COVID-19 has a physical or mental impact and may also affect the immune, endocrine, and other systems. However, the management and treatment of neurological symptoms such as pain are often neglected for patients hospitalized with COVID-19. Based on the China's early experience in the management of COVID-19 symptoms, the possible negative effects of pre-existing chronic pain in patients with COVID-19 and the challenges of COVID-19 prevention and control bring to the diagnosis and treatment of chronic pain are discussed. This review calls to attention the need to optimize pain management during and after COVID-19.
2019年冠状病毒病（COVID-19）全球大流行对人类健康和医疗保健系统构成重大威胁。紧急防控措施阻碍了患者获得疼痛治疗，许多疼痛患者无法获得充分及时的医疗服务。许多COVID-19患者在疾病初期报告有疼痛症状，包括头痛、肌肉疼痛和胸痛。COVID-19患者的持续性疼痛后遗症会对身体或精神产生影响，还可能影响免疫、内分泌等系统。然而，对于因COVID-19住院的患者，疼痛等神经症状的管理和治疗往往被忽视。基于中国在COVID-19症状管理方面的早期经验，讨论了COVID-19患者既往慢性疼痛可能产生的负面影响以及COVID-19防控给慢性疼痛诊断和治疗带来的挑战。本综述呼吁关注在COVID-19期间及之后优化疼痛管理的必要性。
